STRATEGIC INNOVATION FUND EB05 TherapeuticStrategic Innovation Fund Agreement • February 3rd, 2021 • Edesa Biotech, Inc. • Pharmaceutical preparations • Ontario
Between: HER MAJESTY THE QUEEN IN RIGHT OF CANADA (“Her Majesty”) as represented by the Minister of Industry (the “Minister”) And: Edesa Biotech Research, Inc., a corporation duly incorporated under the laws of Ontario, having its head office located at 100 Spy Court, Markham, Ontario L3R 5H6 (the “Recipient”) And: Edesa Biotech, Inc., a corporation duly incorporated under the laws of British Colombia, having its head office located at 100 Spy Court, Markham, Ontario L3R 5H6 (the “Guarantor”)
